SAN JOSE, Calif. and WYLIE, Texas, Jan. 19, 2026 /PRNewswire/ — eNavvi, the leading digital prescription marketplace, today announced a strategic partnership withSAN JOSE, Calif. and WYLIE, Texas, Jan. 19, 2026 /PRNewswire/ — eNavvi, the leading digital prescription marketplace, today announced a strategic partnership with

eNavvi Partners with SandsRx to Expand Sterile and Non-Sterile Compounding for Dermatology, Weight Management, and HRT

SAN JOSE, Calif. and WYLIE, Texas, Jan. 19, 2026 /PRNewswire/ — eNavvi, the leading digital prescription marketplace, today announced a strategic partnership with SandsRx, adding one of Texas’s most respected independent pharmacies to its growing network. This collaboration significantly expands eNavvi’s capabilities, providing prescribers with streamlined access to PCAB-accredited sterile and non-sterile compounding for high-demand specialties including dermatology, urology, weight management, and hormone replacement therapy (HRT).

As demand for personalized medicine grows, the partnership addresses a critical need for reliable, high-quality compounded medications. SandsRx operates state-of-the-art facilities in Wylie and Frisco, Texas, strictly adhering to the industry’s most rigorous standards. Their inclusion in the eNavvi network ensures that providers can prescribe complex formulations—from customized dermatological creams to sterile injectables for weight loss and sexual health—with confidence in the pharmacy’s adherence to established compounding quality and safety standards.

“SandsRx brings a level of dedication to the eNavvi network that directly benefits our prescribers and their patients,” said Dr. Simon Chang, CEO of eNavvi. “SandsRx distinguishes itself through proactive administrative support and seamless patient communication. Adding SandsRx to our network ensures our prescribers have a partner who treats every order with urgency. They remove the complexity from compounding, making high-quality care accessible and stress-free.”

Key Benefits of the SandsRx and eNavvi Partnership:

  • Expanded Therapeutic Access: Immediate access to specialized formulations for Men’s and Women’s Health, including Bioidentical Hormone Replacement Therapy (BHRT), urology, and dermatology.
  • Rigorous Safety Standards: SandsRx is a PCAB-accredited pharmacy, ensuring compliance with USP <795> and <797> standards for sterile and non-sterile compounding.
  • Operational Excellence: Known for combining clinical expertise with exceptional operational support, SandsRx reduces the administrative burden on medical practices.

This partnership marks another milestone in eNavvi’s mission to make prescription price transparency and fulfillment seamless for independent practices and their patients.

About eNavvi eNavvi is a digital prescription platform designed to bring transparency and simplicity to the prescribing process. By connecting physicians directly with a curated network of pharmacies, eNavvi empowers providers to find the best value and availability for their patients.

About SandsRx SandsRx is a premier independent pharmacy based in Texas, specializing in complex sterile and non-sterile compounding. With a focus on patient safety and clinical excellence, SandsRx serves patients across multiple states with personalized medication solutions.

CONTACT: contact@enavvi.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/enavvi-partners-with-sandsrx-to-expand-sterile-and-non-sterile-compounding-for-dermatology-weight-management-and-hrt-302664304.html

SOURCE eNavvi

Market Opportunity
HIRO Logo
HIRO Price(HRT)
$0.0003685
$0.0003685$0.0003685
-5.12%
USD
HIRO (HRT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Teases Another Bitcoin Buy As MSTR Stock Dips to Five-Month Lows

Michael Saylor Teases Another Bitcoin Buy As MSTR Stock Dips to Five-Month Lows

The post Michael Saylor Teases Another Bitcoin Buy As MSTR Stock Dips to Five-Month Lows appeared on BitcoinEthereumNews.com. Michael Saylor, executive chairman of Strategy, remains committed to aggressive Bitcoin acquisitions despite market skepticism. In a recent interview, he hinted at further purchases and accused short sellers of amplifying negative sentiment through bot attacks. Saylor Hints at More Bitcoin Buys Despite MSTR Stock Dip In the conventional Sunday Post on X, Michael Saylor has hinted that his Strategy will continue to purchase Bitcoin. This comes as the company navigates online criticism and market volatility. In an interview with podcaster Natalie Brunell, Saylor shared his conviction that Bitcoin is a valuable long-term investment, despite recent fluctuations. MicroStrategy’s (MSTR) stock recently hit a five-month low of $323 per share, down by 16%. In the meantime, Bitcoin experienced only an 8% decline from its peak.  Source: Google; MSTR Stock Price-September 22nd, 2025 Despite these market dips, Saylor emphasized that the company’s Bitcoin strategy is the best path forward. According to Saylor, the continuous Bitcoin acquisition is central to Strategy’s business model, and he expressed confidence in the asset over time. His remarks show Strategy’s undeterred ambition to stack more BTC during market dips. Strategy Continues Its Bitcoin Acquisition, Now Holding 638,985 BTC Under Saylor’s leadership, Strategy has become a major player in corporate Bitcoin ownership. The company has spent $47 billion on Bitcoin at an average price of $73,913 per BTC. It purchases the asset in bulk, often during price dips. The latest Strategy Bitcoin acquisitions include 1,955 BTC for $217.4 million at an average price of $114,562 per Bitcoin and 525 BTC for $60.2 million at $111,196 per Bitcoin. As of now, Strategy holds a total of 638,985 BTC worth $73.95 billion.  Although Bitcoin’s price briefly peaked at $113,000 before dipping back below $108,000, Saylor remains undeterred. He continues the company’s strategy of acquiring Bitcoin at advantageous prices. MicroStrategy’s position now…
Share
BitcoinEthereumNews2025/09/22 11:10
Here’s the XRP Price If UK Parliament Declares Ripple Key to Global Payments

Here’s the XRP Price If UK Parliament Declares Ripple Key to Global Payments

Ripple’s XRP is trading around $3.00 today, but a new development out of the UK could change everything. According to a tweet from X Finance Bull, Ripple and its token XRP are now being discussed at the UK Parliament as critical infrastructure for global payments.  This isn’t just industry chatter anymore. Lawmakers are looking at
Share
Coinstats2025/09/22 02:00
Watchdog frowns on BARMM move to remove ‘none of the above’ from ballots

Watchdog frowns on BARMM move to remove ‘none of the above’ from ballots

POLLS. Residents queue to vote for the BARMM local elections, at the Ragondingan Central Elementary School, Buadiposo-Buntong, Lanao Del Sur, on May 12, 2025.
Share
Rappler2026/01/21 09:20